CJC-1295 and Ipamorelin: Dosage, Effects, and What to Expect

CJC-1295 and Ipamorelin: Dosage, Effects, and What to Expect

Table of Contents

 

If you train hard and eat well but still feel stuck, your growth hormone may not be working the way it used to. CJC-1295 and ipamorelin are two peptides people pair to nudge the body toward making more of its own growth hormone.

Together, these two peptides signal your pituitary gland to release growth hormone in a more natural pattern. People use the combination for body composition, recovery, and sleep. This guide walks you through how it works, typical dosing, side effects, and where the law stands right now.

What Are CJC-1295 and Ipamorelin?

CJC-1295 and ipamorelin are lab-made peptides that prompt your body to release more growth hormone. Peptides are short chains of amino acids that act like messengers between your cells.

Both belong to a class called growth hormone secretagogues, and each reaches the goal through a different path. One copies a natural hormone signal, and the other works through a separate receptor. If you are new to this, it helps to understand how peptide therapy works before going further.

What Is CJC-1295?

CJC-1295 is a growth hormone-releasing hormone (GHRH) analog. In plain terms, it copies the natural signal that tells your pituitary gland to make growth hormone.

The version used in this peptide combination is usually called CJC-1295 no DAC. It has a short action that keeps your natural growth hormone production in its normal rhythm, rather than flattening it into one long flow.

What Is Ipamorelin?

Ipamorelin is a selective growth hormone secretagogue. It acts on your ghrelin receptors to set off a clean, quick pulse of growth hormone.

Research by Raun and colleagues in 1998 showed that ipamorelin does this without raising cortisol or prolactin, even at high doses (Raun et al., 1998). That selectivity is the main reason people pair it with CJC-1295.

 

What Does CJC-1295 and Ipamorelin Do?

CJC-1295 and ipamorelin raise your growth hormone levels by signaling the pituitary gland in two ways at once. CJC-1295 acts on the GHRH receptor. Ipamorelin acts on the ghrelin receptor.

When both signals arrive together, your pituitary releases a bigger pulse of growth hormone than either peptide does alone. Many people call this a pulse and sustain effect. Ipamorelin starts the burst, and CJC-1295 helps the release last a bit longer.

This pattern is closer to how the human body releases growth hormone on its own. In one human study, single doses of CJC-1295 produced dose-dependent rises in growth hormone and IGF-1 in healthy adults (Teichman et al., 2006). More growth hormone is what drives the changes people are after.

 

What Is CJC-1295 and Ipamorelin Used For?

People use CJC-1295 and ipamorelin to support muscle, fat loss, and sleep. The benefits come from increased growth hormone, not from adding a synthetic growth hormone to your body.

This natural approach is why the CJC-1295 ipamorelin peptide pairing shows up in wellness, anti-aging, and fitness routines. Here is what the two peptides are linked to.

Muscle Growth and Body Composition

Higher growth hormone supports lean muscle growth and recovery. It helps your body repair muscle tissue and slowly increase muscle mass when you train. Many people pair the stack with workouts to sharpen muscle tone and body composition.

Growth hormone also helps you hold onto lean muscle mass as you get older. It plays a role in bone density and the cellular processes that slow with the aging process. The peptides do not build muscle on their own, so your diet and training still do most of the work.

Fat Loss and Metabolism

Growth hormone encourages your body to use stored fat for energy, which can support fat loss. This is why the stack is popular with people working to lower body fat.

It works best alongside good food intake and regular activity, not in place of them. For a wider look at related options, see our guide to peptides for weight loss.

Sleep and Recovery

Your body releases the most growth hormone during deep sleep, so a bedtime dose can support better sleep quality. Users often report deeper sleep and faster recovery after a few weeks.

Better rest can also lift your energy levels during the day and ease that low energy drag. That sleep connection is why CJC-1295 and ipamorelin sit among the peptides for better sleep people look into.

 

CJC-1295 and Ipamorelin Dosage and Protocol

A common research-context dose is 100 to 200 mcg of CJC-1295 with 100 to 300 mcg of ipamorelin per injection. Most plans run the two peptides together once or twice a day.

There is no single correct dose. A qualified medical provider should set yours as part of a personalized plan that fits each individual patient.

Typical Dosage and Ratio

Most protocols match the two peptides close to a 1:1 ratio. A frequent starting point is 100 mcg of each, taken once daily before bed.

Some plans use higher amounts split into two or three doses across the day. Doses are measured in micrograms, so the exact amount you draw depends on how the vial is mixed with bacteriostatic water.

How It's Administered

Both peptides are given as a subcutaneous injection, which goes into the fatty tissue just under your skin. You use a small insulin needle and rotate injection sites to avoid irritation.

Common injection sites include:

  • The abdomen, a couple of inches from your navel
  • The outer thigh
  • The flank, or love handle area

Rotating these spots lets your skin recover between doses. To see how this compares with other formats, read about peptide delivery methods.

Timing, Frequency, and Cycle Length

Timing matters because food can blunt the growth hormone response. A few simple rules help here:

  • Inject on an empty stomach, at least two hours after eating
  • Use a bedtime dose to line up with your natural growth hormone release
  • Many people follow a five days on, two days off pattern
  • Cycles often run 8 to 12 weeks, then a break

The break gives your body a chance to reset before you start again. Sticking to a structured plan keeps your response steady over time.

 

What Are the Side Effects of CJC-1295 and Ipamorelin?

Most reported side effects are mild and fade as your body adjusts. The common ones include water retention, mild nausea, flushing, headache, and dizziness.

Injection site reactions like redness or small bruises can also happen, which is why you rotate spots. Because growth hormone affects blood sugar, the stack can shift your insulin sensitivity over a cycle, so blood glucose is worth tracking.

Serious reactions are rare under medical supervision. Still, you should report lasting joint pain, swelling, or blood sugar changes to your provider. Many of these peptide side effects overlap with what people notice across other peptides in this class.

 

Are CJC-1295 and Ipamorelin FDA Approved?

No. CJC-1295 and ipamorelin are not FDA approved for any use, including wellness, fitness, or anti-aging. They are not sold as approved drugs.

Their compounding status has shifted, though. The FDA placed both peptides in Category 2 of its 503A bulk substances list in 2023, then removed them from Category 2 in September 2024 after the nominations were withdrawn. Both were sent to the Pharmacy Compounding Advisory Committee for review in late 2024, and neither was added to the approved 503A compounding list.

That leaves them in a gray zone today, out of Category 2 but not approved for legal compounding either. When a pharmacy prepares them as compounded medications, the FDA does not check them for safety, strength, or quality before they reach you. This is a moving target, so it helps to keep up with current peptide restrictions in 2026.

 

Is CJC-1295 and Ipamorelin Therapy Right for You?

CJC-1295 and ipamorelin therapy is not right for everyone, and it works best with clinical oversight. A qualified medical provider should review your medical history before treatment begins.

Your initial consultation often covers your health history, current medications, and goals, along with lab testing to set a baseline. From there, a medical professional can build a treatment plan and schedule follow up visits and lab work to track how your body responds. People with a history of cancer are usually advised against it, since growth hormone affects cell growth.

Sourcing matters too. Peptides bought from unverified sellers may be mislabeled or contaminated, so a licensed healthcare provider and pharmacy add real protection.

 

What to Weigh Before You Start

CJC-1295 and ipamorelin can support body composition, recovery, and sleep by raising your own growth hormone levels. The science behind each peptide is solid, but human data on the exact pairing is still limited.

That gap is why a medical professional should guide any decision about your overall health. If the combination fits your health goals, supervised use is the safer path to your overall well-being and overall vitality.

This article is for educational purposes only and is not medical advice. CJC-1295 and ipamorelin are not FDA-approved for human use, and you should speak with a qualified healthcare provider before considering any peptide. Always verify product quality and follow professional guidance.

 

Frequently Asked Questions

How long does Ipamorelin CJC-1295 take to show results?

Most people notice the initial benefits of peptide therapy within a few weeks, usually deeper sleep and more energy. Bigger body composition changes and improved muscle mass tend to show after two to three months of steady use. Results build slowly because the peptides work with your natural cycles.

Can a CJC-1295 cause weight gain?

It can cause a small, temporary gain from water retention, mostly in the first few weeks. This is fluid, not fat, and it usually settles as your body adjusts. Over a full cycle, most people use the stack to support weight loss, since it is linked to fat reduction and lean muscle rather than true weight gain.

Does CJC Ipamorelin affect testosterone?

No. CJC-1295 and ipamorelin act on your growth hormone pathway, not your sex hormones. They do not raise or lower testosterone, and they do not call for post-cycle therapy.

What are the bad side effects of CJC-1295 and Ipamorelin?

Serious side effects are rare when use is supervised. The ones to watch for are lasting joint pain, noticeable swelling, and changes in blood sugar. Tell your healthcare provider about any of these so your plan can be adjusted in time.

Why was CJC-1295 discontinued?

The long-acting version, CJC-1295 with DAC, was tested in clinical trials years ago, but development stopped after a trial participant died. The attending physician believed the death was most likely tied to existing heart disease, not the peptide. Research was halted as a precaution, and no version has since been approved as a drug.

 

Find a provider

Which BPC-157 is better for me?

Not all products meet the same standards.